Oncological diagnosis using 11C-Choline-positron emission tomography in comparison with 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography

Molecular Imaging and Biology

Volumn 6, Issue 3, 2004, Pages 172-179

  Tian, Mei ^a   Zhang, Hong ^a,b   Higuchi, Tetsuya ^a   Oriuchi, Noboru ^a   Endo, Keigo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

11C Choline; Diagnosis; FDG; Oncology; PET

Indexed keywords

CARBON 11; CHOLINE; FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; BONE TUMOR; BRAIN TUMOR; CANCER DIAGNOSIS; CHOLINE UPTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG METABOLISM; DRUG TRANSPORT; DRUG UPTAKE; ESOPHAGUS CANCER; FEMALE; HUMAN; INJECTION; LUNG CANCER; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUTH TUMOR; MYELOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SOFT TISSUE TUMOR; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHOLINE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY;

EID: 2942635387     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mibio.2004.02.003     Document Type: Article

References (30)

1. Hoh C.K. Schiepers C. Seltzer M.A. et al. PET in oncology: will it replace the other modalities? Semin. Nucl. Med 27 1997 94-106
2. Smith T.A. FDG uptake tumour characteristics and response to therapy: a review Nucl. Med. Commun 19 1998 97-105
3. Gallagher B.M. Fowler J.S. Gutterson N.I. et al. Metabolic some factors responsible for the biodistribution of [18F] 2- trapping as a principle of radiopharmaceutical design: deoxy-2-fluoro-D-glucose J. Nucl. Med 19 1978 1154-1161
4. DeGrado T.R. Coleman R.E. Wang S. et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer Cancer Res 611 2001 110-117
5. Effert P.J. Bares R. Handt S. et al. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose J. Urol 155 1996 994-998
6. 11C]choline J. Nucl. Med 38 1997 842-847
7. Hobson R.S. Beynon A.D. Preliminary quantitative microradiography study into the distribution of bone mineralization within the basal bone of the human edentulous mandible Arch. Oral Biol 42 1997 497-503
8. Hara T. Yuasa M. Automated synthesis of [11C]choline, a positron-emitting tracer for tumor imaging Appl. Radiat. Isot 50 1999 531-533
9. 11C -choline PET J. Nucl. Med 41 2000 1507-1513
10. Gauthier S. Diksic M. Yamamoto L. et al. Positron emission tomography with [11C]choline in human subjects Can. J. Neurol. Sci 12 1985 214
11. Hamacher K. Coenen H.H. Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro2-deoxy- D-glucose using aminopolyether supported nucleophilic substitution J. Nucl. Med 27 1986 235-238
12. Zhang H. Inoue T. Alyafei S. et al. Tumour detectability in 2-dimensional and 3-dimensional positron emission tomography using the SET-2400W: a phantom study Nucl. Med. Commun 22 2001 305-314
13. Cook G.J. Fogelman I. Maisey M.N. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation Semin. Nucl. Med 26 1996 308-314
14. Strauss L.G. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients Eur. J. Nucl. Med 23 1996 1409-1415
15. Pieterman R.M. Que T.H. Elsinga P.H. et al. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer J. Nucl. Med 43 2002 167-172
16. Inoue T. Oriuchi N. Kunio M. et al. Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncology Nucl. Med. Commun 20 1999 849-857
17. Anzai Y. Carroll W.R. Quint D.J. et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses Radiology 200 1996 135-141
18. Wahl R.L. Quint L.E. Greenough R.L. et al. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation Radiology 191 1994 371-377
19. Johnston J. Giant cell tumor of bone: the role of the giant cell in orthopedic pathology Orthop. Clin. North Am 8 1977 751-770
20. Ling L. Klein M.J. Sissons H.A. et al. Expression of Ia and monocyte-macrophage lineage antigens in giant cell tumor of bone and related lesions Arch. Pathol. Lab. Med 112 1988 65-69
21. Meszaros K.H. Bagby G.J. Spitzer J.J. Contribution of different organs to increased glucose consumption after endotoxin administration J. Biol. Chem 262 1987 10965-10970
22. Gamelli R.L. Liu H. He L. et al. Augmentation of glucose transporter-1 in macrophages following thermal injury and sepsis in mice J. Leukoc. Biol 59 1996 639-647
23. Zhang H. Tian M. Oriuchi N. et al. Carbon-11-Choline PET for detection of bone and soft tissue tumors in comparison with FDG PET Nucl. Med. Commun 24 2003 273-279
24. Aoki J. Watanabe H. Shinozaki T. et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions Radiology 219 2001 774-777
25. Ohtani T. Kurihara H. Ishiuchi S. et al. Brain tumor imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging Eur. J. Nucl. Med 28 2001 1664-1670
26. Clavo A.C. Brown R.S. Wahl R.L. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia J. Nucl. Med 36 1995 1625-1632
27. Minn H. Clavo A.C. Wahl R.L. Influence of hypoxia on tracer accumulation in squamous cell carcinoma: in vitro evaluation for PET imaging Nucl. Med. Biol 23 1996 941-946
28. 13C-NMR studies of choline and ethanolamine uptake Biochim. Biophys. Acta 1095 1991 5-16
29. Katz-Brull R. Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells: NMR applications of the zero trans method Anticancer Res 16 1996 1375-1380
30. Sasaki M. Kuwabara Y. Ichiya Y. et al. Differential diagnosis of thymic tumors using a combination of 11C-Methionine PET and FDG PET J. Nucl. Med 40 1999 1595-1601